Παραπομπή APA

Cao, Y., Qiu, X., Xiao, G., Hu, H., & Lin, T. (2019). Effectiveness and safety of osimertinib in patients with metastatic EGFR T790M-positive NSCLC: An observational real-world study. PLoS One.

Παραπομπή Chicago Style

Cao, Yabing, Xibin Qiu, Guangli Xiao, Hao Hu, και Tongyu Lin. "Effectiveness and Safety of Osimertinib in Patients With Metastatic EGFR T790M-positive NSCLC: An Observational Real-world Study." PLoS One 2019.

Παραπομπή MLA

Cao, Yabing, et al. "Effectiveness and Safety of Osimertinib in Patients With Metastatic EGFR T790M-positive NSCLC: An Observational Real-world Study." PLoS One 2019.

Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.